Skip to NavigationSkip to content

News

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all such...
GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after accusing the...
In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have bombed, failing to meet their primary...
Bristol-Myers Squibb's immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the drug for...
It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on the same day announced that acquisitions were...
In a step towards improving patients’ access to its treatment for spinal muscular atrophy, Biogen announced that NICE had agreed to evaluate Spinraza...
Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 of the Swiss pharma...
A district court in the US handed down a $5 million penalty and entered a permanent injunction to prevent Dr. Reddy’s from distributing prescription...
20,000 children in the UK have been left with disabilities due to the use of anticonvulsant sodium valproate by mothers during pregnancy in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches